Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spence, J.
Right arrow Articles by Donner, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spence, J.
Right arrow Articles by Donner, A

Stroke, Vol 13, 94-99, Copyright © 1982 by American Heart Association


ARTICLES

Problems in design of stroke treatment trials

JD Spence and A Donner

Critical evaluation of the literature was use to identify remediable flaws in the design of clinical trials of stroke treatment. Trials of dexamethasone, dextran, and glycerol were reviewed. Available studies have in common major weaknesses in case selection (failure to exclude arteriolar strokes due to hemorrhage or lacunar infarction), and failure to estimate required sample size. Problems of case selection can be avoided with computerized tomography; the sample size required to show superiority of active treatment over placebo can be estimated using standard formulas. Prognostic stratification is suggested as a method of overcoming problems of unbalanced allocation. Further studies with improved design are required to evaluate the prospects for medical limitation of cerebral infarct size.


This article has been cited by other articles:


Home page
StrokeHome page
L. Roberts and C. Counsell
Assessment of Clinical Outcomes in Acute Stroke Trials
Stroke, May 1, 1998; 29(5): 986 - 991.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. C. Collins, B. H. Dobkin, and D. W. Choi
Selective Vulnerability of the Brain: New Insights into the Pathophysiology of Stroke
Ann Intern Med, June 15, 1989; 110(12): 992 - 1000.
[Abstract] [PDF]


Home page
Arch NeurolHome page
L. B. Goldstein, C. Bertels, and J. N. Davis
Interrater Reliability of the NIH Stroke Scale
Arch Neurol, June 1, 1989; 46(6): 660 - 662.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
J. Olesen, K. Simonsen, B. Norgaard, M. Gronbaek, O. S. Johansen, A. Krogsgaard, and B. Andersen
Reproducibility and Utility of a Simple Neurological Scoring System for Stroke Patients (Copenhagen Stroke Scale)
Neurorehabil Neural Repair, January 1, 1988; 2(2): 59 - 63.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. D. Spence and R. F. Del Maestro
Hypertension in Acute Ischemic Strokes: Treat
Arch Neurol, October 1, 1985; 42(10): 1000 - 1002.
[Abstract] [PDF]